SOLVEX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SOLVEX
Largest movements
- Tangible fixed assets +€15,476
new in 2025: €15,476
- Receivables within one year +€14,760
up €14,760 (+148%), from €10,000 to €24,760
of which Trade receivables: +€10,990
- Cash -€8,519
down €8,519 (-56.8%), from €15,000 to €6,482
mainly Investment in fixed assets (net) (-€18,702) and Receivables within one year (-€14,760)
- Stocks and contracts +€6,436
new in 2025: €6,436
- Other debts +€29,848
new in 2025: €29,848
- Profit (loss) carried forward -€3,830
new in 2025: -€3,830
- Trade debts +€1,609
new in 2025: €1,609
- Accrued charges and deferred income +€550
new in 2025: €550
- Depreciation +€3,227
new in 2025: €3,227
- Other operating charges +€545
new in 2025: €545
- Financial charges +€241
new in 2025: €241
- Gross operating margin +€183
new in 2025: €183
From the 2024 result to the 2025 result
The net result is not in both sets of accounts; without it the difference cannot be explained line by line.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €25,000 | €53,178 | +€28,178 | +113% |
| Fixed assets | 21/28 | - | €15,476 | +€15,476 | |
| Tangible fixed assets | 22/27 | - | €15,476 | +€15,476 | |
| Plant, machinery and equipment | 23 | - | €15,476 | +€15,476 | |
| Current assets | 29/58 | €25,000 | €37,702 | +€12,702 | +50.8% |
| Stocks and contracts in progress | 3 | - | €6,436 | +€6,436 | |
| Stocks | 30/36 | - | €6,436 | +€6,436 | |
| Amounts receivable within one year | 40/41 | €10,000 | €24,760 | +€14,760 | +148% |
| Trade receivables | 40 | - | €10,990 | +€10,990 | |
| Other amounts receivable | 41 | €10,000 | €13,771 | +€3,771 | +37.7% |
| Cash at bank and in hand | 54/58 | €15,000 | €6,482 | -€8,519 | -56.8% |
| Deferred charges and accrued income | 490/1 | - | €24 | +€24 | |
| Total equity and liabilities | 10/49 | €25,000 | €53,178 | +€28,178 | +113% |
| Equity | 10/15 | €25,000 | €21,170 | -€3,830 | -15.3% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€3,830 | -€3,830 | |
| Amounts payable | 17/49 | - | €32,008 | +€32,008 | |
| Amounts payable within one year | 42/48 | - | €31,458 | +€31,458 | |
| Trade debts | 44 | - | €1,609 | +€1,609 | |
| Suppliers | 440/4 | - | €1,609 | +€1,609 | |
| Other amounts payable | 47/48 | - | €29,848 | +€29,848 | |
| Accrued charges and deferred income | 492/3 | - | €550 | +€550 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €3,227 | +€3,227 | |
| Other operating charges | 640/8 | - | €545 | +€545 | |
| Gross operating margin | 9900 | - | €183 | +€183 | |
| Operating profit (loss) | 9901 | - | -€3,589 | -€3,589 | |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | - | €241 | +€241 | |
| Recurring financial charges | 65 | - | €241 | +€241 | |
| Profit (loss) for the period before taxes | 9903 | - | -€3,830 | -€3,830 | |
| Profit (loss) for the period | 9904 | - | -€3,830 | -€3,830 | |
| Profit (loss) for the period to be appropriated | 9905 | - | -€3,830 | -€3,830 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.